Pregnancy and contraceptive use among women participating in the FEM-PrEP trial

Journal of Acquired Immune Deficiency Syndromes

Volumn 68, Issue 2, 2015, Pages 196-203

  Callahan, Rebecca ^a   Nanda, Kavita ^a   Kapiga, Saidi ^b   Malahleha, Mookho ^c   Mandala, Justin ^a   Ogada, Teresa ^d   Van Damme, Lut ^e   Taylor, Douglas ^a  

^a Kilimanjaro Christian Medical Center ^*  (United States)

^b Kilimanjaro Christian Medical Center   (India)

^c Setshaba Research Centre   (South Africa)

^d IMPACT RESEARCH AND DEVELOPMENT ORGANIZATION   (Kenya)

^e BILL AND MELINDA GATES FOUNDATION   (United States)

Author keywords

adherence; HIV; Preexposure prophylaxis; pregnancy contraception

Indexed keywords

EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; INJECTABLE CONTRACEPTIVE AGENT; ORAL CONTRACEPTIVE AGENT; ADENINE; ANTIRETROVIRUS AGENT; CONTRACEPTIVE AGENT; DEOXYCYTIDINE; EMTRICITABINE; PHOSPHONIC ACID DERIVATIVE; TENOFOVIR DISOPROXIL;

ADULT; ARTICLE; CLINICAL TRIAL (TOPIC); CONTRACEPTIVE BEHAVIOR; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; NAUSEA; PATIENT COMPLIANCE; PREGNANCY; PREGNANCY RATE; PRIORITY JOURNAL; VOMITING; ADOLESCENT; ANALOGS AND DERIVATIVES; CHEMISTRY; HIV INFECTIONS; INCIDENCE; MEDICATION COMPLIANCE; PLASMA; UNPLANNED PREGNANCY; YOUNG ADULT;

ADENINE; ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; CONTRACEPTIVE AGENTS; DEOXYCYTIDINE; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MEDICATION ADHERENCE; ORGANOPHOSPHONATES; PLASMA; PREGNANCY; PREGNANCY RATE; PREGNANCY, UNPLANNED; YOUNG ADULT;

EID: 84921944429     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000413     Document Type: Article

References (26)

1. Sibeko S, Cohen GM, Moodley J. Contraception and pregnancy in microbicide trials. Best Pract Res Clin Obstet Gynaecol. 2012;26: 473-486.
2. Lagakos SW, Gable A; Institute of Medicine (US), Committee on the Methodological Challenges in HIV Prevention Trials, Institute of Medicine (US), Board on Global Health, National Academies (US). Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: National Academies Press; 2008.
3. Raymond EG, Taylor D, Cates W Jr, et al. Pregnancy in effectiveness trials of HIV prevention agents. Sex Transm Dis. 2007;34:1035-1039.
4. Gray GE, Allen M, Moodie Z, et al. Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study. Lancet Infect Dis. 2011;11:507-515.
5. Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329:1168-1174.
6. Chirenje ZM, Marrazzo J. MTN-003 protocol 2.0. Phase 2B safety and effectiveness study of tenofovir 1% gel, tenofovir disoproxil fumarate tablet and emtricitabine/tenofovir disoproxil fumarate tablet for the prevention of HIV infection in women. 2010. Available at: http://www.mtnstopshiv.org/sites/default/files/attachments/MTN-003-FINAL-Version-2.0-31DEC2010.pdf. Accessed August 4, 2014.
7. Facts Consortium. FACTS 001. 2011. Available at: http://factsconsortium. wordpress.com/facts-001-study/facts-001-study-design/. Accessed August 4, 2014.
8. Van Damme L, Corneli A, Ahmed K, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367:411-422.
9. Blanchard K, Bostrom A, Montgomery E, et al. Contraception use and effectiveness among women in a trial of the diaphragm for HIV prevention. Contraception. 2011;83:556-563.
10. Reid SE, Dai JY, Wang J, et al. Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African women. J Acquir Immune Defic Syndr. 2010;53:606-613.
11. Odutola A, Baisley K, Hayes RJ, et al. Pregnancy and contraceptive use among women participating in an HIV prevention trial in Tanzania. Sex Transm Infect. 2012;88:436-443.
12. Ngure K, Heffron R, Mugo NR, et al. Contraceptive method and pregnancy incidence among women in HIV-1-serodiscordant partnerships. AIDS. 2012;26:513-518.
13. Halpern V, Lie CC, Feldblum P, et al. Predictors of pregnancy in microbicide trials. Contraception. 2011;83:436-440.
14. Sibeko S, Baxter C, Yende N, et al. Contraceptive choices, pregnancy rates, and outcomes in a microbicide trial. Obstet Gynecol. 2011;118: 895-904.
15. Trussell J. Contraceptive efficacy. In: Hatcher RA, Trussell J, Nelson AL, et al, eds. Contraceptive Technology: Twentieth Revised Edition. New York, NY: Ardent Media; 2011.
16. Latka MH, Fielding K, Gray GE, et al. Pregnancy incidence and correlates during the HVTN 503 Phambili HIV vaccine trial conducted among South African women. PLoS One. 2012;7:e31387.
17. Matthews LT, Sibeko S, Mansoor LE, et al. Women with pregnancies had lower adherence to 1% tenofovir vaginal gel as HIV preexposure prophylaxis in CAPRISA 004, a phase IIB randomized-controlled trial. PLoS One. 2013;8:e56400.
18. Adams JL, Sykes C, Menezes P, et al. Tenofovir diphosphate and emtricitabine triphosphate concentrations in blood cells compared with isolated peripheral blood mononuclear cells: a new measure of antiretroviral adherence J Acquir Immune Defic Syndr. 2013;62: 260-266.
19. Corneli A, Deese J, Wang M, et al. FEM-PrEP: adherence patterns and factors associated with adherence to a daily oral study product for pre-exposure prophylaxis. J Acquir Immune Defic Syndr. 2014;66: 324-331.
20. SAS/STAT-9.2 User's Guide [computer program]. Version 9.2. Cary, NC: SAS Institute Inc.; 2009.
21. Skoler-Karpoff S, Ramjee G, Ahmed K, et al. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2008; 372:1977-1987.
22. Kearney BP, Mathias A. Lack of effect of tenofovir disoproxil fumarate on pharmacokinetics of hormonal contraceptives. Pharmacotherapy. 2009;29:924-929.
23. Curtis SL, Westoff CF. Intention to use contraceptives and subsequent contraceptive behavior in Morocco. Stud Fam Plann. 1996; 27:239-250.
24. Roy TK, Ram F, Nangia P, et al. Can women's childbearing and contraceptive intentions predict contraceptive demand Findings from a longitudinal study in central India. Int Fam Plan Perspect. 2003;29: 25-31.
25. Ngure KBJ, Mugo N, Curran K, et al. I feared: my intention was a child but I was very afraid: fertility intentions and HIV-1 risk perception among HIV-1 serodiscordant couples in Kenya. International AIDS Conference. Washington, DC; July 22-27, 2012.
26. Hou MY, Hurwitz S, Kavanagh E, et al. Using daily text-message reminders to improve adherence with oral contraceptives: a randomized controlled trial. Obstet Gynecol. 2010;116:633-640.